You just read:

Janssen Biotech, Inc. Announces Collaborative Development and Worldwide License Agreement for Investigational Anti-Cancer Drug, PCI-32765

News provided by

Janssen Pharmaceutical Companies of Johnson & Johnson

Dec 08, 2011, 04:21 ET